The global Glucagon Like Peptide 1 Analogs Market is estimated to be valued at US$ 13.68 Mn in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2024 to 2031, as highlighted in a
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |